Celiac.com 05/26/2025 - Antibiotics are frequently prescribed to young children to treat infections like ear infections or pneumonia. While these medications are effective in fighting bacterial illnesses, there is growing concern that their overuse in early childhood may disrupt the developing gut microbiome—the community of beneficial bacteria in the digestive system. This disruption could potentially contribute to long-term health issues. A large-scale study analyzed data from over a million children in the United Kingdom to explore whether early antibiotic use (before age 2) is linked to chronic conditions such as allergies, autoimmune disorders, or neurodevelopmental conditions later in life.

Study Methods

The researchers examined electronic health records from children born between 1987 and 2020, tracking antibiotic prescriptions given before age 2. They then monitored these children for diagnoses of chronic conditions, including asthma, food allergies, autoimmune diseases (such as celiac disease and type 1 diabetes), and neurodevelopmental disorders (like ADHD and autism). To ensure accuracy, they also compared siblings with different antibiotic exposure histories, helping rule out genetic or environmental factors that might skew results.

Key Findings on Allergic Conditions

The study found a clear connection between early antibiotic use and an increased risk of allergic conditions. Children who received antibiotics before age 2 were more likely to develop:

• Asthma (24% higher risk)
• Food allergies (33% higher risk)
• Allergic rhinitis (hay fever) (6% higher risk)

The risk was even greater for children who had multiple courses of antibiotics, suggesting a dose-dependent relationship.

Autoimmune and Neurodevelopmental Conditions

Unlike allergic conditions, the study did not find strong evidence linking early antibiotic use to most autoimmune diseases, including:

• Celiac disease
• Inflammatory bowel disease (IBD)
• Juvenile idiopathic arthritis
• Type 1 diabetes
• Psoriasis

Similarly, neurodevelopmental conditions such as ADHD, autism, and anxiety disorders did not show a consistent association with early antibiotic exposure. However, there was a notable exception: children who received five or more antibiotic courses had a 73% higher risk of intellectual disability compared to those who had only one or two courses. This finding was even stronger in sibling comparisons, suggesting a possible biological effect rather than just genetic or environmental factors.

Why These Findings Matter

The study reassures parents that while antibiotics may slightly increase the risk of allergies and intellectual disabilities, they do not appear to be a major factor in most autoimmune or neurodevelopmental conditions. However, the findings emphasize the importance of using antibiotics judiciously in young children. Doctors should weigh the benefits against potential long-term risks, especially for mild infections that might resolve without medication.

Implications for People with Celiac Disease

For individuals with celiac disease, this study provides important reassurance. Unlike some previous theories, the research found no significant link between early antibiotic use and the development of celiac disease. This suggests that while gut microbiome changes may influence some health conditions, they do not appear to be a major trigger for celiac disease. Parents of children at risk for celiac disease (due to family history) can focus on other known risk factors, such as genetics and gluten exposure, rather than worrying about past antibiotic use.

Conclusion

This large-scale study highlights that while early antibiotic use may contribute to a higher risk of allergies and, in some cases, intellectual disabilities, most autoimmune and neurodevelopmental conditions—including celiac disease—are not strongly linked to antibiotic exposure. The findings support the careful use of antibiotics in young children, ensuring they are prescribed only when truly necessary. For families managing celiac disease, the results offer relief, confirming that antibiotics are unlikely to be a major factor in disease development. Future research should continue exploring how microbiome changes in early life influence long-term health.

Read more at: academic.oup.com

Celiac.com 05/22/2025 - Celiac disease is an autoimmune disorder in which the immune system mistakenly attacks the lining of the small intestine when gluten—a protein found in wheat, barley, and rye—is consumed. This reaction leads to inflammation, damage to intestinal tissue, and impaired nutrient absorption. While genetics play a significant role in celiac disease, the exact mechanisms by which certain genes contribute to the condition remain unclear.

This study focuses on the HLA-DQA1 gene, a critical player in celiac disease susceptibility. By examining how specific variants of this gene influence immune responses to gluten, researchers hope to uncover new insights into disease development. The study also proposes experiments using genetically modified mice to explore how different HLA-DQA1 variants affect immune reactions and intestinal damage.

Celiac Disease vs. Gluten Sensitivity

Celiac disease is often confused with gluten sensitivity, but they are distinct conditions.

• Celiac Disease: An autoimmune disorder where gluten triggers an immune response that damages the small intestine. This can lead to malnutrition, digestive issues, and long-term health complications.
• Non-Celiac Gluten Sensitivity (NCGS): A less severe condition where gluten causes symptoms like bloating and stomach pain but does not cause intestinal damage.

The study emphasizes celiac disease due to its severe health consequences and strong genetic links.

How Celiac Disease Develops

When someone with celiac disease eats gluten, the immune system reacts abnormally:

1. Gluten Breakdown: Gluten is broken down into smaller proteins, including gliadin, which the immune system sees as a threat.
2. Immune Activation: Specialized immune cells (antigen-presenting cells) present gliadin fragments to T-cells, a type of white blood cell.
3. Inflammatory Response: Activated T-cells release inflammatory chemicals (cytokines) that attract more immune cells, leading to intestinal damage.
4. Tissue Damage: Over time, this immune attack flattens the intestinal villi (finger-like projections that absorb nutrients), causing malabsorption and other symptoms.

A key enzyme called tissue transglutaminase (TG2) worsens this process by modifying gliadin, making it even more recognizable to the immune system.

The Genetic Link: HLA-DQA1 and Celiac Disease

The HLA-DQA1 gene is located on chromosome 6 and plays a crucial role in immune function. It helps the body distinguish between its own cells and foreign invaders. Certain variants of this gene increase the risk of celiac disease by making the immune system more reactive to gluten.

• High-Risk Variants: The HLA-DQ2 and HLA-DQ8 variants are strongly linked to celiac disease. People with these variants are more likely to develop the condition.
• Mechanism: These gene variants produce proteins that bind tightly to gluten fragments, triggering a stronger immune response.

Despite knowing that HLA-DQA1 is involved, researchers still don’t fully understand how different versions of this gene contribute to disease severity.

Proposed Experiments: Studying HLA-DQA1 in Mice

To better understand how HLA-DQA1 variants influence celiac disease, the study outlines a series of experiments using genetically modified mice:

1. Creating HLA-DQA1 Knock-In Mice

Using CRISPR/Cas9 gene editing, researchers will insert human HLA-DQA1 variants into mice. This will allow them to study how these genes affect immune responses to gluten.

2. Testing Immune Reactions

Mice will be fed a gluten-containing diet, and their immune responses will be measured by:

• T-cell activation: Checking if T-cells react to gluten.
• Cytokine production: Measuring levels of inflammatory chemicals.
• Intestinal damage: Examining tissue under a microscope to assess villi damage.

3. Comparing Different Genetic Variants

The study will compare:

• Mice with high-risk HLA-DQA1 variants (expected to show strong immune reactions).
• Mice with low-risk variants (expected to have milder reactions).
• Normal mice (as a control group).

Challenges and Future Research

While mouse studies provide valuable insights, they have limitations:

• Mice do not perfectly replicate human immune responses.
• Environmental factors (like gut bacteria) also influence celiac disease but may differ in mice.

Future research should:

• Study HLA-DQA1 variants in diverse human populations.
• Investigate how other genes and environmental factors interact with HLA-DQA1.
• Develop therapies that target specific immune pathways in celiac disease.

Why This Research Matters for People with Celiac Disease

Understanding the role of HLA-DQA1 could lead to:

• Better Diagnostic Tools: Identifying high-risk genetic variants could help predict who might develop celiac disease.
• Personalized Treatments: Therapies could be tailored based on a person’s specific genetic risk.
• New Therapies: Drugs that block harmful immune responses triggered by HLA-DQA1 could be developed.

Currently, the only treatment for celiac disease is a strict gluten-free diet. However, this research could pave the way for new treatments that address the root cause of the disease—offering hope for better management and improved quality of life for those affected.

By uncovering the genetic and immune mechanisms behind celiac disease, this study brings science one step closer to more effective solutions for patients worldwide.

Read more at: lakeforest.edu

Celiac.com 05/19/2025 - When children are diagnosed with celiac disease, switching to a gluten-free diet is essential for healing and managing symptoms. However, new research suggests that this important dietary change may come with an unexpected side effect: increased exposure to arsenic, a toxic heavy metal found in certain foods—especially rice. This study explored whether children newly diagnosed with celiac disease absorb more arsenic after starting a gluten-free diet and what that might mean for their health.

Why the Study Was Conducted

Celiac disease is an autoimmune condition triggered by eating gluten, a protein found in wheat, barley, and rye. The only treatment is a lifelong gluten-free diet. However, many gluten-free products use rice as a substitute for wheat-based ingredients. Rice has a natural tendency to absorb arsenic from soil and water, especially in areas where the environment is already contaminated. This has raised concerns that children on a gluten-free diet may end up consuming more arsenic through rice-based foods like crackers, cereals, and pasta.

The researchers set out to test this idea by measuring arsenic levels in the urine of children with celiac disease—before and after they started a gluten-free diet.

How the Study Was Done

The study followed children between the ages of 2 and 18 who were undergoing medical testing for celiac disease. Researchers first took urine samples before the children began the gluten-free diet. Then, after six months on the diet, they collected urine samples again to see if arsenic levels had changed.

Out of 67 children who started the study, 50 were officially diagnosed with celiac disease. Ultimately, 35 of those children completed the full study, including urine testing both before and after the dietary shift.

The children in the study mostly came from middle-class, educated families and were primarily white. Most had common celiac symptoms like stomach pain and diarrhea.

What the Study Found

After six months on a gluten-free diet, the researchers found a noticeable increase in the children’s arsenic levels. On average, their urinary arsenic concentration went from 3.3 micrograms per liter before the diet to 13.6 micrograms per liter after switching to gluten-free foods. This was a statistically significant rise, meaning it is very unlikely to be due to chance.

The study also looked at possible factors that might explain why some children had higher arsenic levels than others. Two key findings stood out:

Children with a family history of celiac disease tended to have higher arsenic levels after six months.

Children who identified as Hispanic also had higher levels on average.

These associations might reflect different eating habits, cultural food preferences, or genetic factors, but more research is needed to understand the cause.

What the Results Mean

It’s important to emphasize that while arsenic levels increased, they remained below levels considered immediately dangerous. Still, even low levels of arsenic over long periods have been linked to potential health risks, including effects on brain development, the immune system, and possibly cancer. What this means is that although the levels in this study are not acutely toxic, the long-term effects of mild but continuous exposure—especially in young, growing bodies—are not yet fully understood.

This study does not suggest that families should stop gluten-free diets. For people with celiac disease, eating gluten causes direct damage to the intestines and leads to serious long-term health problems. However, the findings do raise important questions about how to make gluten-free eating as safe and healthy as possible.

What This Means for Families Managing Celiac Disease

For families of children with celiac disease, this study is a reminder to think carefully about the quality and variety of foods included in a gluten-free diet. Many gluten-free packaged foods rely heavily on rice flour and rice-based ingredients, which may increase arsenic intake if consumed regularly. Here are a few tips for managing this concern:

Mix up your grains: Try gluten-free alternatives like quinoa, buckwheat, millet, amaranth, or oats labeled gluten-free. These grains are naturally low in arsenic and offer a broader nutritional profile.

Limit processed foods: Many processed gluten-free snacks and baked goods rely heavily on rice flour. Focusing on whole, unprocessed foods can reduce unnecessary exposure.

Choose rice types carefully: Brown rice tends to have more arsenic than white rice, and rice grown in certain regions (like the southern United States) may contain higher levels. Look for rice from areas known to have lower arsenic content, or rinse rice thoroughly before cooking to reduce levels.

Stay informed: Talk to your doctor or a dietitian about any concerns and stay up to date with new research.

Why This Study Matters

This study shines a light on a little-known issue that could have long-term implications for children managing celiac disease. While going gluten-free is non-negotiable for those with celiac, it’s important to look beyond the label and think about what gluten-free really means nutritionally. By being aware of potential hidden risks like arsenic exposure from rice-based foods, families can make more informed decisions to support their child’s overall health.

The key takeaway? A gluten-free diet should be more than just removing gluten—it should be a balanced, thoughtful approach to nutrition that supports healing without introducing new risks. This research is an important step toward better understanding how to do just that.

Read more at: journals.lww.com

Watch the video version of this article:

Celiac.com 05/12/2025 - Celiac disease is an autoimmune disorder triggered by gluten, affecting millions worldwide. While genetics and diet play key roles, researchers are investigating whether other factors—such as early exposure to certain medications—could influence its development. A recent large-scale study examined whether acid-suppressing medications (like proton-pump inhibitors and histamine-2 blockers) given to infants might be linked to a higher risk of celiac disease later in childhood.

What the Study Investigated

The study analyzed health records of over 79,000 children in Israel, tracking two key factors:

1. Early acid-suppressing medication use – Whether infants received these drugs in their first six months of life.
2. Celiac disease autoimmunity – Detected through blood tests measuring antibodies linked to celiac disease.

Researchers used two different methods to assess the connection:

• Cohort Study: Compared children who took acid reducers with those who didn’t.
• Test-Negative Case-Control Study: Only included children tested for celiac disease, comparing those with positive vs. negative results.

Key Findings

1. Cohort Study Results

• Children who took acid-suppressing medications had a 1.6% rate of celiac autoimmunity, compared to 1.0% in non-users.
• Those who used these medications for more than one month had an even higher risk.
• The study suggested a 52% increased likelihood of developing celiac autoimmunity in early acid-reducer users.

2. Test-Negative Case-Control Results

• Surprisingly, when looking only at children who were tested for celiac disease, no significant link was found between acid reducers and positive test results.
• About 5% of children with celiac autoimmunity had taken acid reducers as infants, compared to 4.6% of those without celiac autoimmunity—a difference too small to be meaningful.

Why the Conflicting Results?

The discrepancy suggests that healthcare behavior—not just medication use—might influence the findings.

• Parents who seek acid-reducing medications for their infants may also be more likely to request celiac testing later, even for mild symptoms.
• The first study method (cohort design) couldn’t account for this bias, while the second method (test-negative design) helped control for it.

What This Means for Families with Celiac Disease

• No Clear Cause-and-Effect: The study does not prove that acid reducers directly cause celiac disease. Instead, it highlights how healthcare habits might skew research results.
• Monitoring Still Important: If a child has taken acid-suppressing medications early in life, parents should stay aware of potential celiac symptoms (digestive issues, fatigue, poor growth) but not assume a direct link.
• Need for Better Research: Future studies should account for healthcare access and testing behaviors to avoid misleading conclusions.

Conclusion: A Call for Cautious Interpretation

While early acid-suppressing medication use was initially linked to higher celiac risk, deeper analysis suggests this connection may be influenced by how often children get tested rather than a true biological effect. For families managing celiac disease, this study reinforces the importance of:

• Watching for symptoms rather than fearing medications alone.
• Understanding research limitations when interpreting medical studies.
• Consulting doctors before making changes to a child’s treatment plan.

Ultimately, more precise studies are needed to determine whether acid reducers play any real role in celiac development—or if the observed link is simply a reflection of healthcare trends.

Read more at: jamanetwork.com

Celiac.com 05/10/2025 - In recent years, avoiding gluten has become increasingly common—even among people who do not have celiac disease. But how many people actually follow a gluten-free diet without a medical need? And what drives this trend? A long-term Finnish study tracked the prevalence and characteristics of adults avoiding gluten without a celiac disease diagnosis over an 11-year period. The findings reveal a significant increase in gluten avoidance, along with insights into the dietary habits and psychological well-being of this group.

Study Design and Methods

Researchers analyzed data from two large, nationwide health surveys conducted in Finland—one in 2000 and another in 2011. These surveys included:

• Health questionnaires covering diet, medical history, and lifestyle
• Blood tests to screen for celiac disease antibodies
• Psychological assessments measuring depression and general well-being

The study focused on adults who reported avoiding gluten but did not have celiac disease or positive celiac-related antibodies. This group was labeled PWAG (People Without Celiac Disease Avoiding Gluten).

Key Findings

1. Gluten Avoidance Increased Dramatically

• In 2000, only 0.2% of Finnish adults avoided gluten without celiac disease.
• By 2011, this number had risen to 0.7%—a more than threefold increase.
• The highest prevalence was in adults over 70 years old (1.3%), suggesting that older individuals are also adopting gluten-free diets.

2. No Clear Medical Reason for Gluten Avoidance

Unlike celiac disease—which is linked to anemia, autoimmune conditions, and genetic risk factors—PWAG showed:

• No higher likelihood of celiac-related health issues before starting a gluten-free diet.
• No signs of pre-celiac disease in blood tests. This suggests that most people avoiding gluten without celiac disease do so for reasons other than undiagnosed celiac risk.

3. Multiple Dietary Restrictions Were Common

People avoiding gluten were also more likely to follow other restrictive diets:

• 41.7% avoided lactose (vs. 12% of the general population).
• 12.5% restricted foods due to allergies (vs. 3% of the general population). This pattern indicates that PWAG may have broader food sensitivities or dietary concerns beyond gluten.

4. Psychological and Lifestyle Differences

• In 2000, PWAG had higher depression scores than the general population.
• By 2011, this difference was no longer significant, but PWAG still visited doctors more frequently and were less likely to work full-time.
• These findings suggest that gluten avoidance may be linked to stress, anxiety, or general health concerns rather than a direct reaction to gluten.

Why This Matters for People with Celiac Disease

1. Differentiating Between Celiac Disease and Non-Celiac Gluten Avoidance

This study confirms that most people avoiding gluten do not have celiac disease. For those with diagnosed celiac disease, this distinction is important because:

• It reinforces that celiac disease is a medically necessary condition, not just a dietary choice.
• It highlights the need for proper testing before assuming gluten is the issue.

2. The Role of Media and Misinformation

The rapid rise in gluten avoidance—without a clear medical cause—suggests that popular health trends and marketing may influence dietary choices. For people with celiac disease, this can lead to:

• Misunderstanding about the seriousness of celiac disease.
• Difficulty finding reliable information about gluten-free diets.

3. Nutritional Risks of Unnecessary Dietary Restrictions

PWAG often followed multiple restrictive diets, increasing the risk of nutrient deficiencies. For celiac patients, this underscores the importance of:

• Working with a dietitian to ensure a balanced gluten-free diet.
• Avoiding unnecessary food restrictions that could worsen health.

4. The Need for Better Support and Education

Since PWAG often reported higher healthcare use and psychological distress, the study suggests that:

• Doctors should assess why patients avoid gluten—whether due to real intolerance, perceived benefits, or other health concerns.
• Mental health and dietary counseling could help those struggling with food-related anxiety.

Conclusion

This study reveals a striking increase in gluten avoidance without celiac disease—a trend likely driven by factors beyond medical necessity, such as dietary trends, perceived health benefits, and psychological well-being. For people with celiac disease, these findings emphasize the importance of:

• Accurate diagnosis to distinguish true celiac disease from self-imposed dietary restrictions.
• Evidence-based dietary guidance to avoid unnecessary restrictions.
• Public education to clarify the differences between celiac disease and non-celiac gluten sensitivity.

As gluten-free diets continue to grow in popularity, further research is needed to understand the long-term effects of gluten avoidance in people without celiac disease—and how healthcare providers can best support those with genuine medical needs.

Read more at: bmcgastroenterol.biomedcentral.com

Celiac.com 05/07/2025 - Non-celiac gluten sensitivity (NCGS) is a condition in which individuals experience gastrointestinal and extraintestinal symptoms after consuming gluten, despite testing negative for celiac disease and wheat allergy. However, the mechanisms behind NCGS remain unclear, and some researchers question whether gluten is truly the primary trigger. A recent study investigated how acute (short-term) and sub-acute (slightly longer-term) gluten exposure affects both physical symptoms and psychological responses in people with NCGS compared to healthy individuals. The findings challenge common assumptions about NCGS and suggest that factors beyond gluten—such as psychological state and nocebo effects—may play a significant role in symptom development.

Study Design and Methods

The study was a randomized, single-blind, crossover trial, meaning participants received both gluten and placebo in different phases without knowing which they were consuming at the time. Researchers tested two types of gluten exposure:

• Acute challenge: Participants consumed a single high dose of gluten (16g) or whey protein (placebo) mixed into yogurt.
• Sub-acute challenge: Participants ate gluten-containing or gluten-free muffins daily for five days.

The study included 16 individuals with self-reported NCGS and 20 healthy controls. Researchers measured:

• Gastrointestinal symptoms (bloating, abdominal pain)
• Psychological responses (mood, fatigue, tension)
• Biological markers (intestinal permeability, inflammation, cortisol levels)

Key Findings

1. Psychological Differences at Baseline

Before any gluten exposure, individuals with NCGS already showed distinct psychological differences compared to healthy controls. They reported:

• Higher levels of negative emotions (such as anxiety or irritability)
• Lower levels of positive emotions (such as happiness or calmness)

This suggests that people with NCGS may have a different psychological baseline, which could influence how they perceive symptoms.

2. Gluten Did Not Cause Unique Physical Symptoms

Contrary to expectations, gluten did not trigger significantly worse gastrointestinal symptoms compared to the placebo in NCGS participants. Instead:

• After acute exposure, NCGS participants reported more fatigue—but this happened with both gluten and placebo.
• After sub-acute exposure, they experienced more bloating and abdominal pain—but again, these symptoms occurred regardless of whether they ate gluten or placebo.

This implies that something other than gluten (such as expectation or other dietary components) may be driving these reactions.

3. No Changes in Biological Markers

The study looked for gluten-related changes in:

• Intestinal permeability ("leaky gut")
• Inflammation (measured by C-reactive protein)
• Stress response (cortisol levels)

None of these markers showed any differences between gluten and placebo, further questioning whether gluten directly causes physiological changes in NCGS.

4. Strong Nocebo Effect Observed

A striking finding was that 56% of NCGS participants reported symptoms after the placebo that they mistakenly attributed to gluten. This "nocebo effect"—where negative expectations cause real symptoms—suggests that belief and anticipation may be major contributors to NCGS reactions.

Why This Matters for People with Celiac Disease

While this study focused on non-celiac gluten sensitivity, the findings have important implications for the celiac disease community:

1. Differentiating Conditions is Crucial

• Celiac disease involves a proven immune reaction to gluten, while NCGS symptoms may be influenced by psychological and expectation-based factors.
• This reinforces the importance of proper testing for celiac disease before assuming gluten is the issue.

2. Nocebo Effects Could Influence Gluten-Free Diets

• Some people with celiac disease may experience anxiety around gluten cross-contamination, which could heighten perceived symptoms even when no gluten was actually consumed.
• Understanding the role of expectation could help in managing dietary adherence and reducing unnecessary stress.

3. Need for Better Diagnostic Approaches

• If NCGS symptoms are not always gluten-specific, future research should explore other dietary triggers (such as FODMAPs or food additives) alongside psychological factors.
• This could lead to more personalized dietary and mental health strategies for those with gluten-related concerns.

Conclusion

This study challenges the idea that NCGS is solely a gluten-driven condition. Instead, it highlights the role of psychological factors and nocebo effects in symptom development. For people with celiac disease, these findings underscore the importance of accurate diagnosis and the potential influence of mindset on symptom perception. Moving forward, healthcare providers may need to consider both dietary and psychological approaches when helping individuals manage gluten-related concerns.

For those with celiac disease, sticking to a strict gluten-free diet remains essential—but understanding the mind-gut connection could lead to better symptom management and improved quality of life.

Read more at: onlinelibrary.wiley.com

Celiac.com 04/24/2025 - Celiac disease is an autoimmune disorder triggered by gluten consumption, leading to damage in the small intestine. While genetic factors, particularly certain HLA types, are known to play a significant role in predisposing individuals to celiac disease, the role of immune cell profiles at birth remains unclear. This study aimed to investigate whether specific immune cell markers at birth could influence the risk of developing celiac disease in childhood. By analyzing dried blood spots collected at birth, researchers explored the potential connections between immune cell profiles and the later onset of celiac disease.

Study Design and Participants

The study involved a regional cohort of 158 children diagnosed with celiac disease, with a median age of seven years at diagnosis. Each child with celiac disease was matched with two healthy comparators, resulting in a total of 316 comparators. The researchers analyzed dried blood spots collected at birth to measure specific immune markers, including T-cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs), which reflect the output of T cells and B cells from the thymus and bone marrow, respectively. Additionally, epigenetic cell counting was used to estimate the percentages of various lymphocyte subsets, such as T cells, B cells, and natural killer (NK) cells.

Key Findings

No Significant Associations Found:
The study found no significant differences in immune cell markers at birth between children who later developed celiac disease and those who did not. TREC and KREC levels, as well as the percentages of T cells, B cells, and NK cells, were similar across both groups. This suggests that immune cell profiles at birth do not play a significant role in determining the risk of celiac disease.

Consistency Across Subgroups:
The results remained consistent when analyzed by sex, HLA type, and age at diagnosis. This further supports the conclusion that immune cell profiles at birth are not predictive of celiac disease development.

Comparison with Other Autoimmune Diseases:
Unlike some other autoimmune conditions, such as juvenile idiopathic arthritis (JIA) and immune thrombocytopenia (ITP), which have been linked to low TREC levels, celiac disease showed no such association. This highlights the unique nature of celiac disease in terms of its immunological triggers.

Discussion

The study’s findings challenge the hypothesis that immune cell profiles at birth significantly influence the risk of developing celiac disease. While other autoimmune conditions have shown associations with low TREC or KREC levels, celiac disease appears to be an exception. This suggests that the mechanisms driving celiac disease may differ from those of other autoimmune disorders.

Environmental factors, such as infections, diet, and gut microbiome composition, have been proposed as potential contributors to celiac disease development. However, this study did not find evidence that immune cell profiles at birth interact with these factors to increase disease risk. Instead, the findings point to the importance of genetic predisposition, particularly HLA types, as the primary determinant of celiac disease susceptibility.

The study also highlights the potential role of early-life immune system development in shaping disease risk. While immune cell profiles at birth may not be predictive, changes in the immune system during the first few months of life could still play a role. For example, previous research has identified specific lipid and cytokine patterns in infants who later develop celiac disease, suggesting that early immune system maturation may be a critical period for disease development.

Strengths and Limitations

The study’s strengths include its use of a novel epigenetic cell counting technique to analyze dried blood spots, which allowed for the examination of prospectively collected samples. The large, well-defined cohort of children with celiac disease and the matched comparator design also add robustness to the findings.

However, the study has some limitations. For ethical reasons, the researchers were unable to collect HLA type and medical history data for the comparators, which could have provided additional insights. Additionally, the median age at diagnosis was seven years, so the findings may not apply to children with very early-onset celiac disease. Finally, while the study focused on the quantity and proportion of immune cells, it did not explore potential functional differences that could influence disease risk.

Conclusion and Implications for Celiac Disease Patients

This study provides valuable insights into the early-life factors that may or may not contribute to the development of celiac disease. By demonstrating that immune cell profiles at birth do not significantly influence disease risk, the findings underscore the importance of genetic predisposition and environmental factors in celiac disease development.

For individuals with celiac disease, this research reinforces the importance of early diagnosis and management, particularly for those with a family history of the condition. While immune cell profiles at birth may not predict disease risk, understanding the genetic and environmental triggers of celiac disease can help guide preventive measures and personalized treatment strategies. Future research should continue to explore the role of early-life immune system development and environmental exposures in shaping disease risk, with the ultimate goal of improving outcomes for individuals with celiac disease.

Read more at: bmcgastroenterol.biomedcentral.com

Celiac.com 04/11/2025 - Celiac disease is a chronic autoimmune condition that affects approximately 1 in 100 people worldwide. Triggered by gluten, a protein found in wheat, barley, and rye, the disease causes inflammation and damage to the small intestine, leading to symptoms like abdominal pain, bloating, and malnutrition. The only treatment currently available is a lifelong gluten-free diet. While this diet helps heal the gut and reduce symptoms, many patients continue to experience gastrointestinal issues. A groundbreaking study, known as the MARCO study, has used magnetic resonance imaging (MRI) to explore how a gluten-free diet impacts the gut physiology of individuals with celiac disease. This research could pave the way for new treatments and a deeper understanding of the condition.

The MARCO Study: A Closer Look

The MARCO study, led by researchers from the University of Nottingham and the Quadram Institute, aimed to investigate the physiological changes in the gut of people with celiac disease before and after adopting a gluten-free diet. The study involved 36 newly diagnosed celiac patients and 36 healthy volunteers. Participants underwent MRI scans, provided blood and stool samples, and were assessed for gut symptoms. After one year on a gluten-free diet, the celiac patients repeated the tests, while the healthy volunteers served as a control group without any dietary changes.

The study revealed several key findings:

1. Increased Gut Symptoms: Newly diagnosed celiac patients reported more gastrointestinal symptoms compared to healthy controls.
2. Slower Food Transit: The movement of food through the small intestine was slower in celiac patients.
3. Higher Bowel Fluid Levels: Patients had more fluid in their small bowel, indicating potential inflammation or malabsorption.
4. Microbiome Imbalance: The gut microbiota of celiac patients showed higher levels of harmful bacteria, such as E. coli, and lower levels of beneficial bacteria, like Bifidobacteria.

After one year on a gluten-free diet, patients experienced improvements in gut symptoms, bowel fluid levels, and food transit time. However, these measures did not return to normal levels, suggesting that a gluten-free diet alone may not fully restore gut health. Additionally, the diet led to a reduction in some beneficial bacteria, likely due to the decreased intake of starch and wheat-based nutrients.

Why MRI Was Key to the Study

MRI played a crucial role in providing detailed images of the gut, allowing researchers to observe changes in bowel fluid, food transit, and overall gut function. Unlike other imaging techniques, MRI is non-invasive and does not use radiation, making it safe for repeated use. By combining MRI with gut microbiome analysis, the study offered a comprehensive view of how celiac disease affects the gut and how a gluten-free diet influences these changes.

Implications for People with Celiac Disease

The findings of the MARCO study have significant implications for individuals with celiac disease:

1. Understanding Persistent Symptoms

Many celiac patients continue to experience gastrointestinal symptoms even after adopting a gluten-free diet. The study’s results suggest that incomplete recovery of gut function and microbiome imbalances may contribute to these ongoing issues. This highlights the need for additional treatments beyond dietary changes.

2. The Role of the Gut Microbiome

The study found that a gluten-free diet can reduce levels of beneficial bacteria in the gut, potentially impacting overall gut health. This underscores the importance of exploring probiotics or dietary supplements to restore a healthy microbiome in celiac patients.

3. Potential for New Therapies

By identifying specific physiological changes in the gut, the study opens the door for developing targeted therapies. For example, treatments that improve food transit time or restore beneficial bacteria could complement a gluten-free diet and enhance quality of life for patients.

4. Personalized Treatment Approaches

The study’s use of MRI and microbiome analysis demonstrates the value of personalized medicine in celiac disease. Future research could focus on tailoring treatments based on individual gut physiology and microbiome profiles.

Future Directions

The MARCO study is a significant step forward in understanding celiac disease and the impact of a gluten-free diet. However, it also raises important questions for future research:

• How can we better restore gut function and microbiome balance in celiac patients?
• Are there specific dietary components or probiotics that could enhance the benefits of a gluten-free diet?
• Can MRI and microbiome analysis be used to monitor treatment progress and predict outcomes?

These questions highlight the need for continued research to improve the lives of people with celiac disease.

Conclusion

The MARCO study has provided valuable insights into how celiac disease affects the gut and how a gluten-free diet influences these changes. While the diet helps alleviate symptoms and improve gut function, it may not fully restore normal physiology or microbiome balance. This research underscores the importance of exploring additional treatments and personalized approaches to better manage celiac disease.

For individuals with celiac disease, the study offers hope for a deeper understanding of their condition and the potential for more effective therapies in the future. By combining advanced imaging techniques like MRI with microbiome analysis, researchers are paving the way for innovative solutions that could transform the management of celiac disease and improve quality of life for patients worldwide.

Read more at: nottingham.ac.uk

Celiac.com 04/05/2025 - Childhood maltreatment is a severe violation of human rights and a recognized global public health concern. Defined as any form of physical, sexual, or emotional abuse, or neglect, it leaves long-lasting impacts on health and well-being. This study investigates the connection between childhood maltreatment and the risk of developing immune-mediated inflammatory disorders, offering new insights into the broader consequences of childhood trauma.

Background: Understanding the Scope of the Problem

Childhood maltreatment is widespread, affecting one in three children globally. It disproportionately impacts children in disadvantaged communities and can vary based on gender, with boys more likely to experience physical abuse and girls more often subjected to sexual abuse. Despite growing awareness and improved reporting, the full extent of childhood maltreatment remains difficult to determine due to the retrospective nature of most data.

Immune-mediated inflammatory disorders are a group of chronic autoimmune and inflammatory conditions, including diseases such as rheumatoid arthritis, celiac disease, psoriasis, and multiple sclerosis. These conditions are caused by immune system dysregulation, leading to inflammation and tissue damage. While there is genetic overlap across these diseases, they manifest in unique ways and are highly disabling. The prevalence of these disorders is increasing, emphasizing the need for better prevention strategies.

Study Overview: Design and Methods

This retrospective cohort study used a large UK primary care database spanning from 1995 to 2021. It compared individuals exposed to childhood maltreatment with those who had no history of maltreatment, matching participants based on age, gender, and general practice. The study aimed to determine whether childhood maltreatment increased the risk of developing immune-mediated inflammatory disorders, focusing on six specific conditions: rheumatoid arthritis, celiac disease, psoriasis, inflammatory bowel disease, multiple sclerosis, and systemic lupus erythematosus.

Researchers used clinical codes to identify cases of childhood maltreatment and tracked participants over time to monitor the development of these disorders. Statistical analyses assessed the relative risk of each condition in individuals with a history of maltreatment compared to those without.

Key Findings: The Impact of Childhood Maltreatment

The study revealed several significant findings regarding the relationship between childhood maltreatment and immune-mediated inflammatory disorders:

1. Increased Risk for Rheumatoid Arthritis and Psoriasis

• Individuals exposed to childhood maltreatment were 39% more likely to develop rheumatoid arthritis and 16% more likely to develop psoriasis compared to those without a history of maltreatment.
• These findings suggest a notable association between early-life trauma and the development of these conditions.

2. No Significant Risk for Certain Disorders

• The study did not find a statistically significant increase in the risk of developing inflammatory bowel disease, multiple sclerosis, or systemic lupus erythematosus in individuals with a history of maltreatment.

3. Reduced Risk for Celiac Disease

• Surprisingly, the study observed a 26% lower risk of developing celiac disease in individuals exposed to childhood maltreatment. This unexpected result requires further research to understand the underlying mechanisms.

4. Gender Differences in Risk

• The study found that the association between childhood maltreatment and immune-mediated inflammatory disorders was more pronounced in females, highlighting the need for further gender-specific research.

Why Do These Connections Exist?

The exact mechanisms linking childhood maltreatment to immune-mediated inflammatory disorders are not yet fully understood, but several theories have been proposed:

• Chronic Stress and Inflammation: Childhood maltreatment can lead to chronic stress, which in turn triggers inflammation in the body. Over time, this inflammation may contribute to the development of autoimmune diseases.
• Dysregulation of the Immune System: Early-life trauma may disrupt normal immune system development, increasing vulnerability to immune-mediated conditions later in life.
• Behavioral and Lifestyle Factors: Individuals with a history of maltreatment may be more likely to engage in behaviors or experience conditions (e.g., smoking, poor diet, or obesity) that increase the risk of inflammatory disorders.

Further research is needed to explore these potential pathways and identify strategies to mitigate the long-term health effects of childhood maltreatment.

Implications for Public Health

The findings of this study underscore the significant and lasting impact of childhood maltreatment on physical health. Given the prevalence of both childhood maltreatment and immune-mediated inflammatory disorders, these results are highly relevant to public health efforts. Key takeaways include:

1. Prevention and Early Intervention: Preventing childhood maltreatment through social programs, education, and support services can help reduce the long-term health burden associated with trauma.

2. Improved Detection and Support: Early identification of individuals who have experienced maltreatment, coupled with targeted interventions, may help lower their risk of developing immune-mediated inflammatory disorders.

3. Gender-Specific Strategies: Since the study found stronger associations in females, gender-specific approaches may be needed to address the unique risks faced by women and girls.

Why This Study Matters for People with Celiac Disease

For individuals with celiac disease, this study provides valuable insights into how early-life experiences might influence autoimmune conditions. While the reduced risk of celiac disease in individuals exposed to childhood maltreatment was unexpected, it highlights the complex relationship between the immune system and early-life trauma. Understanding these connections could lead to new research directions and ultimately improve care and prevention strategies for those at risk of autoimmune diseases.

In conclusion, this study sheds light on the broader health consequences of childhood maltreatment, emphasizing the importance of addressing trauma not only for mental well-being but also for long-term physical health. For those with celiac disease or other immune-mediated inflammatory disorders, this research reinforces the need for a holistic approach to health that considers the interplay between life experiences and immune function.

Read more at: cell.com

Celiac.com 04/03/2025 - The popularity of gluten-free diets has surged in recent years, often driven by health-conscious consumers who believe that avoiding gluten leads to better health outcomes. While a gluten-free diet is essential for individuals with celiac disease, wheat allergies, or non-celiac wheat sensitivity, many people who do not have these conditions are also eliminating gluten from their diets. However, this growing trend comes with nutritional and financial trade-offs that are not always well understood.

Comparing Gluten-Free and Gluten-Containing Products

A study examining 39 gluten-free products and their gluten-containing counterparts found significant differences in nutritional content and cost. On average, gluten-free products contained less protein while having higher amounts of sugar and calories. These findings challenge the common perception that gluten-free foods are inherently healthier.

Additionally, gluten-free products are generally more expensive than their gluten-containing counterparts. The price difference can create financial strain for individuals who need to follow a gluten-free diet for medical reasons. This discrepancy in cost and nutrition highlights a critical need for improved product formulation and consumer awareness.

Nutritional Challenges of a Gluten-Free Diet

Gluten-free products often lack essential nutrients, including dietary fiber and protein. Many manufacturers attempt to compensate for these deficiencies by adding supplements. However, incorporating dietary fiber during the production process can sometimes interfere with protein digestion, reducing the overall nutritional value of the product.

Another concern is the higher sugar content in gluten-free products. Increased sugar consumption has been linked to various health issues, including weight gain, diabetes, and metabolic disorders. Studies suggest that individuals on a long-term gluten-free diet may experience increased body mass index and potential nutritional deficiencies due to the composition of gluten-free foods.

One essential nutrient that gluten-free products frequently lack is arabinoxylan, a type of non-starch polysaccharide found in wheat, rye, and barley. Arabinoxylan is known for its health benefits, including promoting beneficial gut bacteria, improving digestion, and regulating blood sugar levels. The absence of this nutrient in many gluten-free foods could have unintended health consequences.

Limited Nutritional Improvements in Gluten-Free Products

Despite these challenges, some gluten-free products, such as seeded breads, have been formulated to contain significantly higher fiber content than their gluten-containing counterparts. This improvement is largely due to the use of ingredients like pseudo-cereals (such as quinoa and amaranth) and hydrocolloids, which help improve the texture and nutritional quality of gluten-free baked goods.

However, these nutritional improvements are not uniform across all gluten-free products. Regional variations exist, with gluten-free products in certain countries, such as Spain, often having lower fiber content than those in the United States. These inconsistencies suggest that more work is needed to ensure that gluten-free foods are nutritionally adequate across different markets.

The Economic Burden of Gluten-Free Diets

The growing market for gluten-free products reflects increasing consumer demand, with the global gluten-free industry valued at over $7 billion in 2024. In the United States alone, gluten-free product sales are expected to exceed $5.9 billion. However, the percentage of individuals who require a gluten-free diet for medical reasons remains relatively small. Only about 1% of the population has celiac disease, 6% experience non-celiac wheat sensitivity, and even fewer have wheat allergies. Meanwhile, nearly 25% of Americans consume gluten-free products, often for non-medical reasons.

Since gluten-free foods are generally more expensive to produce due to ingredient sourcing and manufacturing constraints, many consumers end up paying a premium for these products without gaining significant health benefits. For those with medical conditions requiring a gluten-free diet, this cost burden can make maintaining proper nutrition more challenging.

The Future of Gluten-Free Food Development

To address these issues, investment in research and development is crucial for creating more nutritionally balanced gluten-free products. Researchers are exploring ways to enhance the nutrient profiles of these foods while ensuring they remain affordable.

One promising avenue is conducting human feeding trials to determine the best formulations for gluten-free products. These trials would help ensure that gluten-free foods provide the necessary nutrients without adverse health effects.

Government collaborations and financial incentives could also help make gluten-free products more cost-competitive. By subsidizing the production of gluten-free ingredients and supporting local sourcing, the overall cost of gluten-free foods could be reduced, benefiting consumers who require these products for medical reasons.

Raising Public Awareness

Educating the public about the realities of gluten-free diets is essential. Many people adopt a gluten-free lifestyle under the false assumption that it is inherently healthier, even though research suggests otherwise. Public health initiatives should focus on helping consumers make informed decisions about their dietary choices.

For individuals who do not medically require a gluten-free diet, it is important to weigh the nutritional drawbacks and financial costs before eliminating gluten from their meals. For those who do need to follow a strict gluten-free diet, increased awareness can drive demand for better and more affordable gluten-free options.

The Impact on Individuals with Celiac Disease

For people with celiac disease, wheat allergies, or gluten sensitivity, a gluten-free diet is not a choice but a necessity. However, the study highlights significant challenges, including the lower nutritional value and higher cost of gluten-free products. While some gluten-free products are improving in terms of fiber content, the overall market still lacks affordable, nutritionally complete options.

This research underscores the need for continued improvements in gluten-free food production, pricing, and public education. Those with celiac disease and other gluten-related disorders should be aware of the nutritional gaps in many gluten-free products and work with dietitians to ensure they are meeting their dietary needs. Meanwhile, for the broader public, this study serves as a reminder that going gluten-free without medical necessity may not be the healthiest or most cost-effective choice.

Read more at: link.springer.com

Watch the video version of this article:

Celiac.com 03/31/2025 - Wheat is a staple food for many people around the world, but for some, it can cause serious health issues. Conditions like celiac disease, non-celiac wheat sensitivity, and baker’s asthma are often triggered by proteins in wheat called amylase/trypsin inhibitors (ATIs). These proteins can cause inflammation and other adverse reactions in sensitive individuals. A recent study compared the ATI content and activity in older wheat varieties (landraces) and modern wheat varieties to determine if breeding practices have changed the protein composition of wheat. The findings have important implications for people with wheat-related disorders.

What Are Amylase/Trypsin Inhibitors (ATIs)?

The Role of ATIs in Wheat

ATIs are a group of proteins found in wheat that play a role in the plant’s defense system. They inhibit enzymes like amylase and trypsin, which are involved in digestion. While these proteins are harmless to most people, they can trigger immune responses in individuals with conditions like celiac disease or non-celiac wheat sensitivity. For these individuals, consuming wheat can lead to symptoms such as bloating, fatigue, and digestive issues.

Why Study ATIs in Wheat?

Over the years, there has been speculation that modern wheat breeding practices might have increased the levels of ATIs, making wheat less tolerable for people with sensitivities. Some have suggested that older wheat varieties (landraces) might be safer because they were not subjected to the same breeding techniques. This study aimed to test these claims by comparing the ATI content and activity in landraces and modern wheat varieties.

Key Findings of the Study

No Significant Differences in ATI Content

The study analyzed 14 landraces (ancient wheat varieties) and six modern wheat varieties over three consecutive years. Researchers measured the total ATI content and the proportion of ATIs relative to crude protein. The results showed no significant differences between landraces and modern varieties. Both groups had similar levels of ATIs, with landraces averaging 7.1% ATI content and modern varieties averaging 7.5%.

Similar Inhibitory Activity

The study also measured the inhibitory activity of ATIs against an enzyme called α-amylase, which is found in human saliva. Again, there were no significant differences between landraces and modern varieties. Both groups showed similar levels of inhibitory activity, indicating that the biological effects of ATIs have not changed significantly over time.

Individual ATI Components

The researchers examined the distribution of individual ATIs within the total ATI content. They found that the composition of ATIs was very similar in both landraces and modern varieties. For example, a protein called 0.19 made up about 31% of the total ATI content in both groups. Other ATIs, such as CM3 and CM17, also showed similar distributions.

Environmental Factors Play a Role

One interesting finding was that the harvest year had a greater impact on ATI content than the type of wheat. In 2022, both landraces and modern varieties had higher ATI levels compared to 2021 and 2023. This suggests that environmental conditions, such as weather or soil quality, may influence ATI content more than genetic factors.

What This Means for People with Celiac Disease and Gluten Sensitivity

No Evidence That Modern Wheat Is Worse

The study found no evidence to support the claim that modern wheat varieties have higher levels of ATIs or are more likely to trigger adverse reactions. Both landraces and modern varieties had similar ATI content and activity, meaning that switching to older wheat varieties is unlikely to provide relief for people with wheat-related disorders.

The Importance of Avoiding Cross-Contamination

For individuals with celiac disease or severe gluten sensitivity, the key takeaway is that all wheat—whether old or new—contains ATIs that can cause problems. This underscores the importance of avoiding cross-contamination and ensuring that gluten-free foods are prepared in dedicated environments.

Potential for Future Research

While the study did not find significant differences between landraces and modern varieties, it did identify a few individual varieties with lower ATI content or activity. These varieties could be promising candidates for future breeding programs aimed at developing wheat that is safer for people with sensitivities.

Conclusion: A Step Toward Better Understanding

This study provides valuable insights into the composition of wheat and its impact on people with wheat-related disorders. By showing that ATI content and activity have not changed significantly over time, the research challenges the notion that modern wheat is inherently worse for health. For individuals with celiac disease or non-celiac wheat sensitivity, the findings emphasize the need for continued vigilance in managing their diets and avoiding cross-contamination.

Ultimately, this study highlights the importance of ongoing research to better understand the complex relationship between wheat proteins and human health. By identifying wheat varieties with lower ATI content, scientists may one day develop safer options for those who struggle with wheat-related disorders. Until then, the focus remains on education, awareness, and ensuring that food preparation practices meet the needs of sensitive individuals.

Read more at: nature.com

Watch the video version of this article:

Celiac.com 03/20/2025 - Celiac disease is an autoimmune condition triggered by the ingestion of gluten, affecting individuals with genetic predispositions. Recent research has explored the relationship between genetic factors and environmental influences in the early development of celiac disease autoimmunity. A large study, conducted through the TEDDY birth cohort, investigated how season of birth, viral infections, and genetic variations in the CD247 gene contribute to the risk of developing celiac disease autoimmunity. The findings shed new light on how these factors interact and may help in identifying at-risk individuals earlier.

Materials and Methods

The study was conducted as part of The Environmental Determinants of Diabetes in the Young (TEDDY) project, an observational study designed to track environmental triggers of autoimmune diseases such as type 1 diabetes and celiac disease. TEDDY followed children from birth to the age of 15 years, spanning three research centers in both the United States and Europe.

Participants were selected based on genetic screening for specific high-risk HLA haplotypes. The initial screening involved 424,788 infants, out of which 21,583 carried the relevant genetic markers. From this group, 8,676 families agreed to participate, and 6,523 children were ultimately included in long-term monitoring for celiac disease autoimmunity. These children were followed until the age of 10, with 1,262 (19.4%) developing celiac disease autoimmunity. The median age for seropositivity was 3.3 years, with the earliest documented case occurring at just 10 months of age.

Regular follow-ups were conducted quarterly until the children turned four, after which visits were scheduled biannually. Early life health data was gathered through maternal questionnaires administered three months postpartum, while additional information about infections and dietary habits was collected from caregiver-maintained diaries. These records included details on the nature, onset, and medical diagnosis of illnesses, as well as the timing of gluten introduction.

Season of Birth and Autoimmunity Risk

One of the significant findings of the study is that the risk of developing celiac disease autoimmunity varies depending on the season in which a child is born. Specifically, children born between March and August were found to be at a higher risk compared to those born in other months. This suggests that environmental exposures during pregnancy or early infancy may influence immune system development in ways that predispose certain children to autoimmunity.

The Role of the CD247 Gene

The study identified a specific genetic factor that interacts with seasonal birth effects. The CD247 gene, which plays a crucial role in immune system signaling, was found to influence the risk of developing celiac disease autoimmunity. Children who had a particular genetic variation (AA genotype of the rs864537 variant) in the CD247 gene and were born in the spring or summer months were at an increased risk. This suggests that the genetic makeup of the immune system interacts with seasonal environmental exposures, influencing disease development.

Early-Life Infections and Immune Response

Another important finding was the relationship between febrile infections during infancy and the development of celiac disease autoimmunity. Children with the AA genotype in the CD247 gene who experienced infections between the ages of three to six months had an elevated risk. This suggests that immune responses to infections during critical periods of immune development may contribute to the onset of autoimmunity.

Potential Mechanisms Behind the Findings

Researchers suggest that variations in CD247 expression levels may affect immune function from an early age. The study found that children with the high-risk genotype had lower expression of the CD247 gene, which could impact T-cell responses. Since the immune system plays a crucial role in distinguishing harmful substances from harmless ones, changes in immune signaling pathways could contribute to a loss of tolerance to gluten, leading to celiac disease.

Interaction Between Diet and Immune Development

The study also examined how diet influences autoimmunity risk. It was found that the increased risk associated with season of birth and genetics was only present in children who were introduced to gluten before seven months of age. This suggests that early exposure to gluten, in combination with genetic and environmental factors, may play a role in triggering celiac disease autoimmunity. However, breastfeeding did not appear to have a strong protective effect in this particular study.

Implications for People with Celiac Disease

These findings highlight the complex interplay between genetic predisposition and environmental factors in the development of celiac disease. The study provides valuable insights that could help refine risk models and guide future research into prevention strategies. Understanding the role of CD247 in immune function may also lead to new approaches for early detection and potential interventions to reduce the risk of celiac disease autoimmunity.

Conclusion

This study underscores the importance of considering both genetic and environmental factors in understanding autoimmune diseases like celiac disease. The discovery that season of birth, infections, and genetic variations interact to influence disease risk provides new directions for research and potential clinical applications. In the future, screening for genetic risk factors combined with environmental monitoring may help identify children at higher risk, leading to earlier interventions and improved management of celiac disease.

Read more at: nature.com